🇺🇸 FDA
Patent

US 9775876

Compositions and methods for CaMKII inhibitors and uses thereof

granted A61KA61K38/10A61K38/45

Quick answer

US patent 9775876 (Compositions and methods for CaMKII inhibitors and uses thereof) held by The Regents of the University of Colorado, a Body Corporate expires Mon Sep 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado, a Body Corporate
Grant date
Tue Oct 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K38/10, A61K38/45, A61K38/55, A61K45/06